AGENUS INC — Director's Dealing 2017

Apr 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (agen)
CIK: 0001098972
Period of Report: 2017-03-31

Reporting Person: Cuillerot Jean-Marie (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-31	Stock Option, Right to buy	$3.77	A	232500	Acquired	2027-03-31	Common Stock (232500)	Direct

Footnotes

F1: Options vest one-third on the one year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date.